Abingworth as of Sept. 30, 2019
Portfolio Holdings for Abingworth
Abingworth holds 14 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Common (PSNL) | 50.5 | $80M | 5.4M | 14.67 | |
| Crispr Namen Akt (CRSP) | 16.3 | $26M | 628k | 40.97 | |
| Exicure Common | 10.0 | $16M | 6.3M | 2.52 | |
| Sientra Common | 9.8 | $16M | 2.4M | 6.47 | |
| Soleno Common | 4.4 | $6.9M | 4.7M | 1.48 | |
| Paratek Common | 2.9 | $4.5M | 1.0M | 4.33 | |
| Verona Sponds Adr (VRNA) | 2.6 | $4.1M | 902k | 4.57 | |
| Aeglea Common | 1.2 | $1.8M | 241k | 7.69 | |
| Chiasma Common | 1.2 | $1.8M | 371k | 4.93 | |
| Obseva Common | 0.5 | $731k | 88k | 8.31 | |
| Cymabay Common | 0.4 | $670k | 131k | 5.11 | |
| Proteon Common | 0.3 | $525k | 2.0M | 0.26 | |
| Sierra Oncology Common | 0.1 | $83k | 217k | 0.38 | |
| Ocugen Common | 0.0 | $20k | 7.1k | 2.81 |
